Nkarta, Inc.

SOUTH SAN FRANCISCO, CA How do I update this listing?

Nkarta is based out of South San Francisco. Nkarta, Inc. operates as a biotech company. The Company develops and discovers therapies for immune systems and cancer indications. Nkarta serves patients in the State of California. The firm last filed a Form D notice of exempt offering of securities on 2019-09-06. The notice included securities offered of Equity

Create Alert

Contact Info

nkarta, inc.
6000 SHORELINE COURT
SOUTH SAN FRANCISCO CA    94080

Business Phone: 415-582-4923
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2019-09-06 D BIOTECHNOLOGY Equity 114,636,678 43,899,296 70,737,382
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALI BEHBAHANI subscription required
    DIRECTOR
FOUAD AZZAM subscription required
    DIRECTOR
JILL CARROLL subscription required
    DIRECTOR
MATTHEW PLUNKETT subscription required
    EXECUTIVE OFFICER
MICHAEL DYBBS subscription required
    DIRECTOR
PAUL HASTINGS subscription required
    EXECUTIVE OFFICER DIRECTOR
TIBA AYNECHI subscription required
    DIRECTOR

Elevate your investments